Analyst Reco. RemeGen Co., Ltd.

Equities

Market Closed - Hong Kong S.E. Other stock markets 04:09:09 2024-04-25 am EDT			5-day change	1st Jan Change
30.25 ^HKD	+2.89%		+11.62%	-19.23%

Apr. 04	Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication	MT
Apr. 02	Remegen Co., Ltd. Announces FDA Grants Telitacicept Fast Track designation for Treatment of pSS	CI

UBS Adjusts RemeGen's Price Target to HK$75.20 From HK$75.03, Keeps at Buy	22-09-02	MT
UBS Upgrades RemeGen to Buy From Neutral, Adjusts Price Target to HK$75.03 From HK$108	22-04-11	MT

No results for this search